Structural Basis of Chemokine Receptor Function--a Model for Binding Affinity and Ligand Selectivity

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2006 Oct 7

PMID 17024562

Citations 77

Authors

Lavanya Rajagopalan

Krishna Rajarathnam

Affiliations

Soon will be listed here.

Abstract

Chemokine receptors play fundamental roles in human physiology from embryogenesis to inflammatory response. The receptors belong to the G-protein coupled receptor class, and are activated by chemokine ligands with a range of specificities and affinities that result in a complicated network of interactions. The molecular basis for function is largely a black box, and can be directly attributed to the lack of structural information on the receptors. Studies to date indicate that function can be best described by a two-site model, that involves interactions between the receptor N-domain and ligand N-terminal loop residues (site-I), and between receptor extracellular loop and the ligand N-terminal residues (site-II). In this review, we describe how the two-site model could modulate binding affinity and ligand selectivity, and also highlight some of the unique chemokine receptor features, and their role in function.

Citing Articles

An in silico framework to visualize how cancer-associated mutations influence structural plasticity of the chemokine receptor CCR3.

van Aalst E, Wylie B Protein Sci. 2024; 34(1):e70013.

PMID: 39723881 PMC: 11670309. DOI: 10.1002/pro.70013.

Molecular basis for chemokine recognition and activation of XCR1.

Zhang X, Schlimgen R, Singh S, Tomani M, Volkman B, Zhang C Proc Natl Acad Sci U S A. 2024; 121(48):e2405732121.

PMID: 39565315 PMC: 11621518. DOI: 10.1073/pnas.2405732121.

Biophysical characterization of the CXC chemokine receptor 2 ligands.

Martin P, Kurth E, Budean D, Momplaisir N, Qu E, Simien J PLoS One. 2024; 19(4):e0298418.

PMID: 38625857 PMC: 11020491. DOI: 10.1371/journal.pone.0298418.

Heterodimers Are an Integral Component of Chemokine Signaling Repertoire.

Kaffashi K, Dreau D, Nesmelova I Int J Mol Sci. 2023; 24(14).

PMID: 37511398 PMC: 10380872. DOI: 10.3390/ijms241411639.

Hollow Hydroxyapatite Microspheres Loaded with rhCXCL13 to Recruit BMSC for Osteogenesis and Synergetic Angiogenesis to Promote Bone Regeneration in Bone Defects.

Zeng J, Xiong S, Zhou J, Wei P, Guo K, Wang F Int J Nanomedicine. 2023; 18:3509-3534.

PMID: 37404852 PMC: 10317543. DOI: 10.2147/IJN.S408905.

References

Shi X, Liu S, Xiangyu J, Zhang Y, Huang J, Liu S . Structural analysis of human CCR2b and primate CCR2b by molecular modeling and molecular dynamics simulation. J Mol Model. 2002; 8(7):217-22. DOI: 10.1007/s00894-002-0089-6. View

Luster A . The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol. 2002; 14(1):129-35. DOI: 10.1016/s0952-7915(01)00308-9. View

Rajarathnam K, Sykes B, Kay C, DEWALD B, Geiser T, Baggiolini M . Neutrophil activation by monomeric interleukin-8. Science. 1994; 264(5155):90-2. DOI: 10.1126/science.8140420. View

Katancik J, Sharma A, De Nardin E . Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2. Cytokine. 2000; 12(10):1480-8. DOI: 10.1006/cyto.2000.0742. View

Preobrazhensky A, Dragan S, Kawano T, Gavrilin M, Gulina I, Chakravarty L . Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region. J Immunol. 2000; 165(9):5295-303. DOI: 10.4049/jimmunol.165.9.5295. View

Clark-Lewis I, Schumacher C, Baggiolini M, Moser B . Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J Biol Chem. 1991; 266(34):23128-34. View

Loetscher P, Gong J, DEWALD B, Baggiolini M, Clark-Lewis I . N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem. 1998; 273(35):22279-83. DOI: 10.1074/jbc.273.35.22279. View

Hoogewerf A, Kuschert G, Proudfoot A, Borlat F, Clark-Lewis I, Power C . Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry. 1997; 36(44):13570-8. DOI: 10.1021/bi971125s. View

Yan Z, Zhang J, Holt J, Stewart G, Niewiarowski S, Poncz M . Structural requirements of platelet chemokines for neutrophil activation. Blood. 1994; 84(7):2329-39. View

10.

Martin L, Blanpain C, Garnier P, Wittamer V, Parmentier M, Vita C . Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry. 2001; 40(21):6303-18. DOI: 10.1021/bi002670n. View

11.

Rajagopalan L, Rajarathnam K . Ligand selectivity and affinity of chemokine receptor CXCR1. Role of N-terminal domain. J Biol Chem. 2004; 279(29):30000-8. DOI: 10.1074/jbc.M313883200. View

12.

Moser B, Wolf M, Walz A, Loetscher P . Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004; 25(2):75-84. DOI: 10.1016/j.it.2003.12.005. View

13.

Fernando H, Chin C, Rosgen J, Rajarathnam K . Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor. J Biol Chem. 2004; 279(35):36175-8. DOI: 10.1074/jbc.C400283200. View

14.

Handel T, Johnson Z, Crown S, Lau E, Proudfoot A . Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. Annu Rev Biochem. 2005; 74:385-410. DOI: 10.1146/annurev.biochem.72.121801.161747. View

15.

Lalani A, McFadden G . Evasion and exploitation of chemokines by viruses. Cytokine Growth Factor Rev. 2000; 10(3-4):219-33. DOI: 10.1016/s1359-6101(99)00018-0. View

16.

Rajarathnam K, Kay C, DEWALD B, Wolf M, Baggiolini M, Clark-Lewis I . Neutrophil-activating peptide-2 and melanoma growth-stimulatory activity are functional as monomers for neutrophil activation. J Biol Chem. 1997; 272(3):1725-9. DOI: 10.1074/jbc.272.3.1725. View

17.

Murphy P, Baggiolini M, Charo I, Hebert C, Horuk R, Matsushima K . International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev. 2000; 52(1):145-76. View

18.

Datta-Mannan A, Stone M . Chemokine-binding specificity of soluble chemokine-receptor analogues: identification of interacting elements by chimera complementation. Biochemistry. 2004; 43(46):14602-11. DOI: 10.1021/bi048990e. View

19.

Springael J, Urizar E, Parmentier M . Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev. 2005; 16(6):611-23. DOI: 10.1016/j.cytogfr.2005.05.005. View

20.

Skelton N, Quan C, Reilly D, Lowman H . Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. Structure. 1999; 7(2):157-68. DOI: 10.1016/S0969-2126(99)80022-7. View